BIRC5 and ovarian cancer: This system significantly inhibited cell viability (about 70% reduction in ovarian cancer cell line) and enhanced cell sensitivity to PTX in a variety of cancer cell lines, while effectively overcoming drug resistance by down-regulating survivin protein level and disrupting microtubule structure in drug-resistant cell line SKOV3-tr [88].